Impact BiomedicalIBO
13F holders, Q3 2025 (September 30)21holders +2
4new positions
2sold out
$0.66avg. 13F price*
At the end of Q3 2025, 21 institutions reported holding Impact Biomedical Inc. (IBO) in their 13F filings, up 2 from Q2 2025. 4 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($168K), Vanguard Group Inc. ($68K) and Geode Capital Management, LLC ($30K).
- Company
- Impact Biomedical Inc.
- CUSIP
- 45259L205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $32K |
| Exits | 2 | $13K |
All 13F filers, Q2 2025 → Q3 2025: 127,315 shares bought and 60,774 shares sold, net +66,541 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| BlackRock, Inc. | 0.00% | No change | 252,730 | $168K |
| Vanguard Group Inc. | 0.00% | Add +217.3% | 102,905 | $68K |
| Geode Capital Management, LLC | 0.00% | Reduce -9.6% | 45,109 | $30K |
| Two Sigma Investments, LP | 0.00% | Add +38.8% | 31,500 | $21K |
| Two Sigma Securities, LLC | 0.00% | New | 28,441 | $19K |
| Susquehanna International Group, LLP | 0.00% | Reduce -32.0% | 20,962 | $14K |
| UBS Group AG | 0.00% | Reduce -49.4% | 20,088 | $13K |
| State Street Corp. | 0.00% | No change | 11,797 | $8K |
| Mason & Associates Inc | 0.00% | New | 10,000 | $7K |
| Morgan Stanley | 0.00% | New | 9,266 | $6K |
| Citigroup Inc. | 0.00% | Reduce -61.3% | 3,396 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.5% | 1,442 | $959 |
| Wells Fargo & Company | 0.00% | Add +772.4% | 253 | $168 |
| Bank of America Corp. | 0.00% | Add +110.0% | 168 | $111 |
| NFSG Corp | 0.00% | No change | 86 | $57 |
| FMR LLC | 0.00% | No change | 36 | $24 |
| Signature Resources Capital Management, LLC | 0.00% | No change | 4 | $3 |
| Danske Bank A/S | 0.00% | No change | 3 | $2 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
| Cwm, LLC | 0.00% | Add +2700.0% | 28 | $0 |
"% of holder's portfolio" is IBO's weight in each manager's 13F, not the share of Impact Biomedical Inc. the manager owns.